IDXX
Price
$390.94
Change
+$9.11 (+2.39%)
Updated
Apr 11 closing price
Capitalization
44.84B
19 days until earnings call
SYK
Price
$350.28
Change
+$1.89 (+0.54%)
Updated
Apr 11 closing price
Capitalization
134.94B
18 days until earnings call
Ad is loading...

IDXX vs SYK

Header iconIDXX vs SYK Comparison
Open Charts IDXX vs SYKBanner chart's image
IDEXX Laboratories
Price$390.94
Change+$9.11 (+2.39%)
Volume$1.33M
Capitalization44.84B
Stryker
Price$350.28
Change+$1.89 (+0.54%)
Volume$1.77M
Capitalization134.94B
IDXX vs SYK Comparison Chart
Loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IDXX vs. SYK commentary
Apr 13, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IDXX is a Hold and SYK is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 13, 2025
Stock price -- (IDXX: $390.94 vs. SYK: $350.28)
Brand notoriety: IDXX and SYK are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: IDXX: 160% vs. SYK: 107%
Market capitalization -- IDXX: $44.84B vs. SYK: $134.94B
IDXX [@Medical Specialties] is valued at $44.84B. SYK’s [@Medical Specialties] market capitalization is $134.94B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IDXX’s FA Score shows that 1 FA rating(s) are green whileSYK’s FA Score has 3 green FA rating(s).

  • IDXX’s FA Score: 1 green, 4 red.
  • SYK’s FA Score: 3 green, 2 red.
According to our system of comparison, SYK is a better buy in the long-term than IDXX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IDXX’s TA Score shows that 4 TA indicator(s) are bullish while SYK’s TA Score has 4 bullish TA indicator(s).

  • IDXX’s TA Score: 4 bullish, 6 bearish.
  • SYK’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, SYK is a better buy in the short-term than IDXX.

Price Growth

IDXX (@Medical Specialties) experienced а -0.71% price change this week, while SYK (@Medical Specialties) price change was +1.30% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.20%. For the same industry, the average monthly price growth was -2.98%, and the average quarterly price growth was -3.81%.

Reported Earning Dates

IDXX is expected to report earnings on Aug 05, 2025.

SYK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Medical Specialties (-0.20% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SYK($135B) has a higher market cap than IDXX($44.8B). IDXX has higher P/E ratio than SYK: IDXX (52.87) vs SYK (42.99). SYK YTD gains are higher at: -2.489 vs. IDXX (-5.442). SYK has higher annual earnings (EBITDA): 4.93B vs. IDXX (1.22B). SYK has more cash in the bank: 3.05B vs. IDXX (454M). IDXX has less debt than SYK: IDXX (1.07B) vs SYK (13B). SYK has higher revenues than IDXX: SYK (20.5B) vs IDXX (3.66B).
IDXXSYKIDXX / SYK
Capitalization44.8B135B33%
EBITDA1.22B4.93B25%
Gain YTD-5.442-2.489219%
P/E Ratio52.8742.99123%
Revenue3.66B20.5B18%
Total Cash454M3.05B15%
Total Debt1.07B13B8%
FUNDAMENTALS RATINGS
IDXX vs SYK: Fundamental Ratings
IDXX
SYK
OUTLOOK RATING
1..100
6867
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
599
SMR RATING
1..100
1854
PRICE GROWTH RATING
1..100
6254
P/E GROWTH RATING
1..100
7333
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SYK's Valuation (19) in the Medical Specialties industry is somewhat better than the same rating for IDXX (83). This means that SYK’s stock grew somewhat faster than IDXX’s over the last 12 months.

SYK's Profit vs Risk Rating (9) in the Medical Specialties industry is somewhat better than the same rating for IDXX (59). This means that SYK’s stock grew somewhat faster than IDXX’s over the last 12 months.

IDXX's SMR Rating (18) in the Medical Specialties industry is somewhat better than the same rating for SYK (54). This means that IDXX’s stock grew somewhat faster than SYK’s over the last 12 months.

SYK's Price Growth Rating (54) in the Medical Specialties industry is in the same range as IDXX (62). This means that SYK’s stock grew similarly to IDXX’s over the last 12 months.

SYK's P/E Growth Rating (33) in the Medical Specialties industry is somewhat better than the same rating for IDXX (73). This means that SYK’s stock grew somewhat faster than IDXX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IDXXSYK
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
72%
Momentum
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 2 days ago
51%
MACD
ODDS (%)
Bearish Trend 2 days ago
71%
Bearish Trend 2 days ago
42%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
44%
Advances
ODDS (%)
Bullish Trend 17 days ago
70%
Bullish Trend 11 days ago
58%
Declines
ODDS (%)
Bearish Trend 5 days ago
70%
Bearish Trend 5 days ago
49%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
69%
Aroon
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
42%
View a ticker or compare two or three
Ad is loading...
IDXX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ZLAB29.545.22
+21.46%
Zai Lab Limited
SLND3.200.16
+5.26%
Southland Holdings
WLKP22.480.48
+2.18%
Westlake Chemical Partners LP
AER91.981.61
+1.78%
Aercap Holdings NV
CTHR0.80N/A
-0.61%
Charles & Colvard Ltd.

IDXX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IDXX has been loosely correlated with IQV. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if IDXX jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IDXX
1D Price
Change %
IDXX100%
+2.39%
IQV - IDXX
50%
Loosely correlated
+1.63%
SYK - IDXX
48%
Loosely correlated
+0.54%
MYGN - IDXX
48%
Loosely correlated
+0.63%
ALC - IDXX
42%
Loosely correlated
+3.00%
SNN - IDXX
42%
Loosely correlated
+3.19%
More

SYK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYK has been closely correlated with BSX. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if SYK jumps, then BSX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYK
1D Price
Change %
SYK100%
+0.54%
BSX - SYK
67%
Closely correlated
+1.11%
ISRG - SYK
65%
Loosely correlated
+0.83%
MDT - SYK
51%
Loosely correlated
+0.44%
IQV - SYK
50%
Loosely correlated
+1.63%
ABT - SYK
49%
Loosely correlated
+1.91%
More